Bionano Genomics Inc (BNGO)
0.95
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.945
0.00 (0.00%)
After-Hours: 20:00
Bionano Genomics Accounts Receivable (Quarterly): 9.319M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.319M |
September 30, 2023 | 8.669M |
June 30, 2023 | 7.613M |
March 31, 2023 | 6.78M |
December 31, 2022 | 7.022M |
September 30, 2022 | 5.829M |
June 30, 2022 | 4.851M |
March 31, 2022 | 5.514M |
December 31, 2021 | 4.934M |
September 30, 2021 | 2.996M |
June 30, 2021 | 2.838M |
March 31, 2021 | 1.992M |
December 31, 2020 | 2.775M |
Date | Value |
---|---|
September 30, 2020 | 3.86M |
June 30, 2020 | 3.249M |
March 31, 2020 | 4.115M |
December 31, 2019 | 6.334M |
September 30, 2019 | 6.001M |
June 30, 2019 | 4.984M |
March 31, 2019 | 4.057M |
December 31, 2018 | 4.514M |
September 30, 2018 | 4.001M |
June 30, 2018 | 2.886M |
March 31, 2018 | 2.536M |
December 31, 2017 | 3.352M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
1.992M
Minimum
Mar 2021
9.319M
Maximum
Dec 2023
5.246M
Average
4.984M
Median
Jun 2019
Accounts Receivable (Quarterly) Benchmarks
Bruker Corp | 475.40M |
Azenta Inc | 155.93M |
Harvard Bioscience Inc | 16.10M |
Akoya Biosciences Inc | 16.99M |
Singular Genomics Systems Inc | 0.565M |